EP2968460
PROTEIN FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.3.2014EP published:
6.1.2021EP application number:
14721569.3
EPO information:
European Patent Register
Max expiry date:
6.3.2034
Title:
PROTEIN FORMULATIONS
Timeline
Today
7.3.2014EP application
6.1.2021EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
PARK, SungaeAddress:
Thousand Oaks, California 91320, US
Name:
KUHNS, ScottAddress:
Newbury Park, California 91320, US
Name:
RATTAN, JenniferAddress:
Thousand Oaks, California 91360, US
Name:
PHILLIPS, JosephAddress:
Newbury Park, California 91320, US
Priority
Number:
201361775974 PDate:
11.3.2013Country:
US
Classification
Categories:
A61K 39/395, A61K 38/18, A61K 9/19, A61K 47/42, A61K 47/26, A61K 47/02, C07K 16/22